|
|
Thomson Financial Business Description:
| The Group's principal activity is commercialising intellectual property that is developed at universities and similar establishments. It focuses on hormone replacement and angiogenesis compounds. The Group also has operations relating to vaccine adjuvants, cytokine therapies, stem cell therapy, drug metabolism and chronic wound therapy. The Group operates predominantly in the United Kingdom. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Fusion IP PLC
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
